Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
- Conditions
- Scleroderma (Limited and Diffuse)
- Registration Number
- NCT07015060
- Lead Sponsor
- Université Catholique de Louvain
- Brief Summary
Identify rare variants in candidate genes and pathways identified in familial SSc, in patients with sporadic SSc.
Perform (spatial) transcriptomic and proteomic analyses of affected skin from patients with and without cutaneous fibrosis, for the patterns and levels of expression/activation of candidate genes and pathways.
Test for dysregulation of expression/activation of candidate genes and pathways in live cells isolated from the blood and skin biopsy of patients, and for the impact of these dysregulations on cell appearance, behavior and function.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 15
-
Patients diagnosed with one of the following:
- Limited SSc
- Limited cutaneous SSc
- Diffuse cutaneous SSc
-
Patients followed regularly in consultations at CUSL.
-
Patients between ages 18-80.
- Other (co-occurring) autoimmune/autoinflammatory disease
- Pregnancy
- Participants with temporary or definitive disabilities to give consent
- Participants unable to sign or read the inform consent form
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Identify rare variants in candidate genes and pathways in SSC patients (blood and skin biopsy) Through the entire study, approximately during 5 years Genetic analyses in affected skin from patients (Next Generation sequencing, (single cell) RNASeq, real time qPCR)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.